文献速递腹部泌尿生殖妇产影像CT

卵巢癌术前CT腹膜癌指数评估与手术结局及生存相关

Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival.
PubMed 文献 · Radiol Med · 2020-04-01

回顾性观察性队列研究纳入297例卵巢癌患者,由两名放射科医生用Sugarbaker图评估术前CT腹膜癌指数(CT-PCI)。CT-PCI与术后残留病变正相关(OR 1.04),预测完全肉眼肿瘤清除的AUC为0.64;CT未见腹膜病变者无病生存期更长(HR 2.28),放射学浆膜小肠受累是总生存期缩短的独立预测因子(HR 3.01)。

要点

  • 术前CT-PCI与术后残留病变正相关(OR 1.04,95%CI 1.01-1.07,p=0.003)。
  • CT-PCI预测完全肉眼肿瘤清除的AUC仅0.64,作为分诊工具性能较低。
  • CT未见腹膜病变者DFS更长(HR 2.28,p=0.007);放射学浆膜小肠受累是OS缩短的独立预测因子(HR 3.01,p=0.002)。

核心结论

  • 术前CT评估的腹膜癌指数与细胞减灭术后残留病变概率相关,但作为可靠识别可能实现完全细胞减灭术患者的分诊试验性能较低。
  • CT-PCI与DFS和OS均正相关,可能作为独立预后因素使用,例如用于高FIGO分期患者。

研究设计与样本

  • 回顾性观察性队列研究,单中心进行。
  • 纳入2008年至2010年间接受初次细胞减灭术且有术后临床随访至2015年12月的卵巢癌患者,共297例。
  • 两名放射科医生审阅CT扫描并使用Sugarbaker图评估CT-PCI。
  • 采用ROC曲线分析评估CT-PCI评分对手术结局的判别能力,采用Kaplan-Meier非参数曲线和多变量Cox回归分析评估DFS和OS。

诊断标准与关键数值

  • CT-PCI与术后残留病变正相关:OR 1.04,95%CI 1.01-1.07,p=0.003。
  • ROC曲线分析预测完全肉眼肿瘤清除的AUC为0.64。
  • 多变量分析中,CT未见腹膜病变患者DFS显著更长:HR 2.28,p=0.007。
  • 放射学浆膜小肠受累是OS缩短的独立预测因子:HR 3.01,p=0.002。

临床应用与阅片要点

  • 阅片时可参照Sugarbaker图评估CT-PCI,并注意放射学浆膜小肠受累,后者是OS缩短的独立预测因子(HR 3.01,p=0.002)。
  • CT-PCI预测完全肉眼肿瘤清除的AUC为0.64,原文结论认为其作为分诊试验性能较低,不能可靠识别可能实现完全细胞减灭术的患者。
  • CT未见腹膜病变者DFS更长(HR 2.28,p=0.007),CT-PCI可能作为独立预后因素用于高FIGO分期患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate whether Peritoneal Cancer Index (PCI) assessed on preoperative CT (CT-PCI) can be used as non-invasive preoperative tool to predict surgical outcome, disease-free survival (DFS) and overall survival (OS).

MATERIALS AND METHODS: This is a retrospective, observational cohort study performed in a single institution. We considered all patients with diagnosis of ovarian cancer and preoperative CT, who had undergone upfront cytoreductive surgery between 2008 and 2010 and had post-operative clinical follow-up to December 2015. Two radiologists reviewed CT scans and assessed CT-PCI using Sugarbaker's diagram. We assessed the discriminatory capacity of the CT-PCI score on the surgical outcome by ROC curve analysis. DFS and OS were assessed by Kaplan-Meier nonparametric curves and by multivariable Cox-regression analysis.

RESULTS: A total of 297 patients were included in the present analysis. CT-PCI was positively correlated with post-operative residual disease [odds ratio (OR) 1.04, 95% CI 1.01-1.07, p = 0.003]. ROC curve analysis returned AUC = 0.64 for the prediction of total macroscopic tumour clearance. In multivariable analysis, patients with no peritoneal disease seen on CT had a significantly longer DFS [Hazard ratio (HR) 2.28, p = 0.007]. Radiological serosal small bowel involvement was an independent predictor for shorter OS (HR 3.01, p = 0.002).

CONCLUSION: Radiological PCI assessed on preoperative CT is associated with the probability of residual disease after cytoreductive surgery; however, it has low performance as a triage test to reliably identify patients who are likely to have complete cytoreductive surgery. CT-PCI is positively correlated with both DFS and OS and may be used as an independent prognostic factor, for example in patients with high FIGO stages.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Avesani G, Arshad M, Lu H, et al. Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival. Radiol Med. 2020. PMID: 32239470. doi:10.1007/s11547-020-01170-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。